NVO stock news
This page provides real-time market news, earnings updates, and company announcements related to Novo Resources Corp. (NVO).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-15 11:47 EST
NVIDIA Expands Open Model Families to Power the Next Wave of Agentic, Physical and Healthcare AI
Finviz2026-03-16 20:18:45
Food giant General Mills recently announced an asset divestiture plan covering two key supply chain facilities located in Pouso Alegre and Campo Novo Do Parecis, Brazil.
老虎证券2026-03-17 11:23:38
Telemedicine company Hims & Hers Health Inc. (NYSE: HIMS) announced that its service platform will expand its product range to include Novo Nordisk's Wegovy® (semaglutide) oral tablets and injections, as well as Ozempic® injections.
老虎证券2026-03-18 13:00:34
Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851
Finviz2026-03-23 11:33:56
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
Finviz2026-03-24 13:18:49
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-24 20:12:10
Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026
Finviz2026-03-24 20:30:48
LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia
Finviz2026-03-25 12:03:55
Rani Therapeutics Appoints Jesper Hoiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
Finviz2026-03-25 20:57:45
Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance
Finviz2026-03-26 10:03:48
Remote pharmacy Hims launches weight loss membership service offering GLP-1 weight loss medications
华尔街见闻2026-03-26 16:20:39
Scalable Biotech Manufacturing Unlocks a $14B Market
Finviz2026-03-27 13:18:08
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Finviz2026-03-28 14:12:37
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
Finviz2026-03-30 12:33:40
Weight Watchers Announces Best in Market Self-Pay Wegovy Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare
Finviz2026-03-31 11:54:53
Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress
Finviz2026-03-31 12:03:48
LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program
Finviz2026-03-31 12:48:56
Lexaria to Begin New Human Clinical Study in GLP-1
Finviz2026-04-01 13:27:48
Why Is The US Stock Market Up Today?
CryptoNewsNet2026-04-01 21:36:48
Bitget UEX Daily | Trump Plans to Declare Iran War Victory Closure; SpaceX Secret IPO; Storage and Optical Communication Strong Rebound (April 2, 2026)
Bitget2026-04-02 01:30:42
More than 600,000 prescriptions have been issued for oral semaglutide weight loss drug; Novo Nordisk CEO says weight loss drug market has only scratched the surface
格隆汇2026-04-06 07:17:28
Novo Nordisk prices high-dose Wegovy at $399 per month, lower than Eli Lilly's Zepbound
格隆汇2026-04-07 14:29:10
Spectral AI to Feature DeepView System at 2026 American Burn Association Annual Meeting
Finviz2026-04-09 12:33:06
Real-World Evidence and Industry Momentum Builds for iMDx's Flagship GraftAssure Assay
Finviz2026-04-14 12:06:47
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
Finviz2026-03-24 13:18:49
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-24 20:12:10
Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026
Finviz2026-03-24 20:30:48
LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia
Finviz2026-03-25 12:03:55
Rani Therapeutics Appoints Jesper Hoiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
Finviz2026-03-25 20:57:45
Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance
Finviz2026-03-26 10:03:48
Remote pharmacy Hims launches weight loss membership service offering GLP-1 weight loss medications
华尔街见闻2026-03-26 16:20:39
Scalable Biotech Manufacturing Unlocks a $14B Market
Finviz2026-03-27 13:18:08
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Finviz2026-03-28 14:12:37
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
Finviz2026-03-30 12:33:40
Weight Watchers Announces Best in Market Self-Pay Wegovy Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare
Finviz2026-03-31 11:54:53
Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress
Finviz2026-03-31 12:03:48
LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program
Finviz2026-03-31 12:48:56
Lexaria to Begin New Human Clinical Study in GLP-1
Finviz2026-04-01 13:27:48
Why Is The US Stock Market Up Today?
CryptoNewsNet2026-04-01 21:36:48
Bitget UEX Daily | Trump Plans to Declare Iran War Victory Closure; SpaceX Secret IPO; Storage and Optical Communication Strong Rebound (April 2, 2026)
Bitget2026-04-02 01:30:42
More than 600,000 prescriptions have been issued for oral semaglutide weight loss drug; Novo Nordisk CEO says weight loss drug market has only scratched the surface
格隆汇2026-04-06 07:17:28
Novo Nordisk prices high-dose Wegovy at $399 per month, lower than Eli Lilly's Zepbound
格隆汇2026-04-07 14:29:10
Spectral AI to Feature DeepView System at 2026 American Burn Association Annual Meeting
Finviz2026-04-09 12:33:06
Real-World Evidence and Industry Momentum Builds for iMDx's Flagship GraftAssure Assay
Finviz2026-04-14 12:06:47
NVO stock chart
NVO stock detailsNVO stock price change
On the last trading day, NVO stock closed at 0.09 CAD, with a price change of 0.00% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more